Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-16 Sale | 2024-08-20 6:03 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 18,714 | $75.08 | $1,405,047 | 29,700 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 8:31 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 20,477 | $66.23 | $1,356,110 | 37,045 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 7:58 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,907 | $70.13 | $554,491 | 29,700 (Direct) | View |
| 2024-02-02 Sale | 2024-02-05 6:07 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 11,860 | $67.15 | $796,367 | 29,700 (Direct) | View |
| 2023-11-06 Sale | 2023-11-08 5:31 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 42,393 | $55.63 | $2,358,152 | 29,700 (Direct) | View |
| 2023-08-07 Sale | 2023-08-09 6:05 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 55,300 | $58.79 | $3,251,087 | 45,339 (Direct) | View |
| 2023-03-28 Sale | 2023-03-30 5:08 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 15,604 | $54.31 | $847,380 | 45,339 (Direct) | View |
| 2023-03-10 Sale | 2023-03-13 7:35 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 12,308 | $43.84 | $539,599 | 75,633 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 7:03 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,241 | $50.01 | $362,122 | 49,199 (Direct) | View |
| 2023-02-24 Sale | 2023-02-27 8:03 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 4,046 | $47.12 | $190,648 | 64,347 (Direct) | View |
| 2023-02-21 Sale | 2023-02-22 8:05 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 3,898 | $47.01 | $183,246 | 52,580 (Direct) | View |
| 2022-04-08 Sale | 2022-04-08 6:56 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 86,348 | $64.37 | $5,558,051 | 45,339 (Direct) | View |
| 2022-02-24 Sale | 2022-02-25 7:08 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,906 | $52.21 | $412,810 | 61,152 (Direct) | View |
| 2022-02-22 Sale | 2022-02-23 7:07 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 11,139 | $55.29 | $615,827 | 56,478 (Direct) | View |
| 2022-01-10 Sale | 2022-01-11 8:06 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 20,948 | $40.78 | $854,255 | 45,339 (Direct) | View |
| 2021-10-18 Sale | 2021-10-19 4:26 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 13,448 | $40.86 | $549,551 | 45,339 (Direct) | View |
| 2021-02-19 Sale | 2021-02-22 8:07 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 5,184 | $39.22 | $203,308 | 67,617 (Direct) | View |
| 2021-01-11 Sale | 2021-01-12 7:06 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 9,684 | $32.02 | $310,082 | 60,332 (Direct) | View |
| 2020-10-16 Sale | 2020-10-16 4:04 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 6,792 | $26.8 | $182,026 | 41,568 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-16 Exercise | 2024-08-20 6:03 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 18,714 | $36.89 | 29,700 (Direct) | View |
| 2024-08-16 Exercise | 2024-08-20 6:03 pm | N/A 2031-02-22 | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 18,714 | $0 | 29,700 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-11 8:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,345 | $0 | 37,045 (Direct) | View |
| 2024-03-06 Exercise | 2024-03-08 5:59 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 13,132 | $0 | 69,098 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 26,227 | $0 | 26,227 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 7:58 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,907 | $0 | 29,700 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 6:07 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 11,860 | $0 | 29,700 (Direct) | View |
| 2023-11-06 Exercise | 2023-11-08 5:31 pm | N/A 2030-02-17 | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 26,754 | $0 | 29,700 (Direct) | View |
| 2023-11-06 Exercise | 2023-11-08 5:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 26,754 | $23.94 | 29,700 (Direct) | View |
| 2023-08-07 Exercise | 2023-08-09 6:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 55,300 | $18.59 | 45,339 (Direct) | View |
| 2023-08-07 Exercise | 2023-08-09 6:05 pm | N/A 2028-10-14 | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 55,300 | $0 | 45,339 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-13 7:35 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 16,708 | $0 | 75,633 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-13 7:35 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,344 | $0 | 75,633 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 7:52 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 39,398 | $0 | 39,398 (Direct) | View |
| 2023-02-23 Exercise | 2023-02-27 8:03 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,906 | $0 | 64,347 (Direct) | View |
| 2023-02-18 Exercise | 2023-02-22 8:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 11,139 | $0 | 52,580 (Direct) | View |
| 2022-04-08 Exercise | 2022-04-08 6:56 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 86,348 | $12.73 | 45,339 (Direct) | View |
| 2022-04-08 Exercise | 2022-04-08 6:56 pm | N/A 2029-01-07 | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 86,348 | $0 | 45,339 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:13 pm | N/A 2032-03-09 | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 39,950 | $0 | 39,950 (Direct) | View |
| 2022-02-23 Exercise | 2022-02-25 7:08 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,906 | $0 | 61,152 (Direct) | View |
| 2022-02-18 Exercise | 2022-02-23 7:07 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 11,139 | $0 | 56,478 (Direct) | View |
| 2022-01-08 Exercise | 2022-01-11 8:06 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 20,948 | $0 | 45,339 (Direct) | View |
| 2021-10-15 Exercise | 2021-10-19 4:26 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 13,448 | $0 | 45,339 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 4:24 pm | N/A 2031-02-22 | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 42,433 | $0 | 42,433 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 8:07 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 11,139 | $0 | 67,617 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 7:06 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 20,948 | $0 | 60,332 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-16 4:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 13,448 | $0 | 41,568 (Direct) | View |
| 2020-02-18 Option Award | 2020-02-20 7:30 pm | N/A 2020-02-17 | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 60,171 | $0 | 60,171 (Direct) | View |
| 2020-01-08 Other | 2020-01-10 9:11 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 6,157 | $26.34 | 69,517 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 9:11 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 20,947 | $0 | 69,517 (Direct) | View |